Laobaixing Pharmacy (603883) - Total Assets
Based on the latest financial reports, Laobaixing Pharmacy (603883) holds total assets worth CN¥20.34 Billion CNY (≈ $2.98 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 603883 book value for net asset value and shareholders' equity analysis.
Laobaixing Pharmacy - Total Assets Trend (2011–2024)
This chart illustrates how Laobaixing Pharmacy's total assets have evolved over time, based on quarterly financial data.
Laobaixing Pharmacy - Asset Composition Analysis
Current Asset Composition (December 2024)
Laobaixing Pharmacy's total assets of CN¥20.34 Billion consist of 41.0% current assets and 59.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.7% |
| Accounts Receivable | CN¥2.95 Billion | 13.3% |
| Inventory | CN¥3.57 Billion | 16.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥845.35 Million | 3.8% |
| Goodwill | CN¥5.76 Billion | 26.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how Laobaixing Pharmacy's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Laobaixing Pharmacy (603883) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laobaixing Pharmacy's current assets represent 41.0% of total assets in 2024, a decrease from 73.6% in 2011.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2024, down from 24.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 8.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 26.0% of total assets.
Laobaixing Pharmacy Competitors by Total Assets
Key competitors of Laobaixing Pharmacy based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.47 Billion |
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Oriola-KD Oyj A
HE:OKDAV
|
Finland | €963.50 Million |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.27 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.93 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$346.42 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
Laobaixing Pharmacy - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.87 | 0.85 | 0.90 |
| Quick Ratio | 0.50 | 0.48 | 0.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.27 Billion | CN¥-1.54 Billion | CN¥-656.61 Million |
Laobaixing Pharmacy - Advanced Valuation Insights
This section examines the relationship between Laobaixing Pharmacy's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.66 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | CN¥22.16 Billion |
| Market Capitalization | $1.54 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Laobaixing Pharmacy's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Laobaixing Pharmacy's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Laobaixing Pharmacy (2011–2024)
The table below shows the annual total assets of Laobaixing Pharmacy from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥22.16 Billion ≈ $3.24 Billion |
+4.36% |
| 2023-12-31 | CN¥21.23 Billion ≈ $3.11 Billion |
-0.78% |
| 2022-12-31 | CN¥21.40 Billion ≈ $3.13 Billion |
+26.18% |
| 2021-12-31 | CN¥16.96 Billion ≈ $2.48 Billion |
+50.28% |
| 2020-12-31 | CN¥11.28 Billion ≈ $1.65 Billion |
+13.70% |
| 2019-12-31 | CN¥9.92 Billion ≈ $1.45 Billion |
+16.97% |
| 2018-12-31 | CN¥8.48 Billion ≈ $1.24 Billion |
+26.66% |
| 2017-12-31 | CN¥6.70 Billion ≈ $980.26 Million |
+36.44% |
| 2016-12-31 | CN¥4.91 Billion ≈ $718.44 Million |
+29.18% |
| 2015-12-31 | CN¥3.80 Billion ≈ $556.14 Million |
+50.24% |
| 2014-12-31 | CN¥2.53 Billion ≈ $370.17 Million |
+16.06% |
| 2013-12-31 | CN¥2.18 Billion ≈ $318.96 Million |
+34.94% |
| 2012-12-31 | CN¥1.62 Billion ≈ $236.37 Million |
+6.25% |
| 2011-12-31 | CN¥1.52 Billion ≈ $222.46 Million |
-- |
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more